U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT06806241) titled 'Effects of Tranexamic Acid Irrigation on Impacted Third Molar Surgery' on Jan. 27.
Brief Summary: Tranexamic acid (TXA) is an effective hemostatic agent used to reduce blood loss and the need for transfusion. It is a relatively safe drug with minimal significant side effects. The most commonly reported complications include nausea, diarrhea, and occasional orthostatic reactions. The increased risk of thromboembolic events associated with the drug is the most serious complication; however, this has not been reported in most clinical studies and remains uncertain. Based on experience from other types of surgeries, tranexamic acid appea...